Delivery Order SPE2DB20D2104-SPE2DB25FNBEW
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dasatinib 20 mg tablets (60-count units) with a ceiling value of $2,077.39. This is a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The contract was competitively awarded with no set-aside designation and is being...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $53,650.40 to AmerisourceBergen Drug Corp on September 29, 2025, with completion scheduled for September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, with primary...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order valued at $10,472.64 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitive award, issued with no set-aside designation, represents a child order under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $99,722.94 to AmerisourceBergen Drug Corp on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract calls for pharmaceutical products and medical supplies to...
- The Department of Defense awarded a delivery order valued at $1.81M to AmerisourceBergen Drug Corp on September 10, 2025, through the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order is due for completion by September 11, 2025, and represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The order will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $139,894.92 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $22,821.58 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $41,482.50 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.999 billion ceiling value through December 2026. The delivery order represents a single...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,593.00 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. The delivery order, which is a child action under a larger contract vehicle, carries a firm fixed price and is scheduled for completion by September 30, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical or medical supply procurement fulfilling federal healthcare requirements for military and...